Colorado biotech's knee osteoarthritis drug gets good results, stock soars

Ampio Pharmaceuticals reports good news about a trial for its Ampion treatment for osteoarthritis-of-the knee; its shares soar in early Thursday trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.